glp-1 compound podcast The Status of & the FDA with Tanna Donelson, P.A.-C Compounded GLP-1 Treatment

Its about to get a lot harder to get cheap GLP-1s: Rising costs may force consumers to cut back on discretionary spending, creating headwinds for retailers already fearing tariff-driven cost increases.

Nonalcoholic fatty liver disease (NAFLD) represents a burgeoning problem in hepatology, and is associated with insulin resistance

Forbes just released their list of top-rated GLP-1 providers for 2025

Get insights on navigating GLP-1 antagonist shortages and compounds as we navigate demand and supply challenges.

Learn how to access a 3 or 6-month subscription pl

This helps prep the skin for better absorption of active ingredients